- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
BEAT
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
Heartbeam Inc · Healthcare · Health Information Services
Latest close
0.51 USD
-8.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -56.1% below the Trend Line and sits at 0.3% of its 52-week range. The latest completed week returned -8.5%, after a -24.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.
Setup score
15
out of 100
Latest Close
0.51 USD
24 Jul 2026
1W Return
-8.5%
latest completed week
4W Return
-24.2%
short-term follow-through
12W Return
-42.0%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-8.5%
Latest completed week; four-week move -24.2%.
Indicator stack
8/39
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.51%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
58/100
42 relevant articles in the latest sentiment read.
Event risk
11d
Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -56.1% below the Trend Line and sits at 0.3% of its 52-week range. The latest completed week returned -8.5%, after a -24.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0012-week average 0.00
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -24.2% over four weeks, -42.0% over 12 weeks, and -59.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change18.6%Four-week change in activity pressure.
Leadership-65.08Latest relative-leadership reading.
RS change-13.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 64%
Model confidence 61%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality52/100Profitability and accounting quality. Underlying universe rank 49; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth53/100Revenue and earnings growth. Underlying universe rank 48; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -46.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -27.6% Net share repurchases relative to market value.
- Shareholder yield
- -27.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity12 / 0
12 acquisitions and 0 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment58/100
Weighted news tone is neutral across 42 relevant articles.
19 positive · 19 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings11dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-87.2%Distance below the 52-week high.
13-week volatility6.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher7 of 2619 weeks finished lower.
Best week+8.4%Week of 15 May.
Worst week-20.0%Week of 17 Apr.
Latest week-8.5%Week of 24 Jul.
Shape of recent returns
Strong gains4
Modest gains3
Flat weeks0
Modest losses7
Sharp losses12
Recent vol6.8%13-week weekly-return volatility.
Base vol32.5%52-week weekly-return volatility.
Up/down split17/34Count of positive and negative weeks in the 52-week window.
Average skew22.0% / -9.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average0.9%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Health Information Services
4-week rank39 / 42
Group average1.1%
Trend breadth45.2%
Trend45.2%active weekly trend signals
MD81.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape17/100
Trend, activity pressure, participation, and risk combine to a 17/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.00; No reversal markers Next-Week ExpectancyNegative 37.51%Next-week expectancy is negative with a 37.51% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 93 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is neutral across 42 relevant articles.
LPL Financial’s (NASDAQ:LPLA) Q2 CY2026 Sales Beat Estimates, Stock Soars Insiders12 / 012 acquisitions and 0 disposals in the latest 180-day insider tape.
Earnings11dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 0.51 USD | -8.5% | 1.17 USD | 1.81 USD | -0.72 | -65.08 | 2.0M | Off |
| 17 Jul 2026 | 0.56 USD | -7.6% | 1.23 USD | 1.83 USD | -0.70 | -62.96 | 15.9M | Off |
| 10 Jul 2026 | 0.60 USD | -16.0% | 1.31 USD | 1.84 USD | -0.75 | -62.08 | 2.2M | Off |
| 3 Jul 2026 | 0.72 USD | 6.6% | 1.37 USD | 1.86 USD | -0.78 | -54.61 | 1.9M | Off |
| 26 Jun 2026 | 0.68 USD | -11.1% | 1.37 USD | 1.88 USD | -0.89 | -57.55 | 2.9M | Off |
| 19 Jun 2026 | 0.76 USD | 0.2% | 1.37 USD | 1.89 USD | -0.96 | -54.99 | 2.8M | Off |
| 12 Jun 2026 | 0.76 USD | -9.7% | 1.38 USD | 1.90 USD | -1.06 | -54.61 | 3.4M | Off |
| 5 Jun 2026 | 0.84 USD | -4.1% | 1.40 USD | 1.91 USD | -1.06 | -49.36 | 3.9M | Off |
| 29 May 2026 | 0.88 USD | -0.4% | 1.43 USD | 1.92 USD | -1.12 | -50.35 | 1.9M | Off |
| 22 May 2026 | 0.88 USD | -9.0% | 1.46 USD | 1.93 USD | -1.18 | -49.56 | 2.4M | Off |
| 15 May 2026 | 0.96 USD | 8.4% | 1.49 USD | 1.94 USD | -1.23 | -44.82 | 5.9M | Off |
| 8 May 2026 | 0.89 USD | 0.9% | 1.51 USD | 1.95 USD | -1.26 | -49.90 | 3.1M | Off |
| 1 May 2026 | 0.88 USD | -2.4% | 1.54 USD | 1.95 USD | -1.19 | -48.58 | 3.1M | Off |
| 24 Apr 2026 | 0.90 USD | -1.8% | 1.57 USD | 1.96 USD | -1.11 | -47.45 | 6.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.